Ghezzi has Confirmed very little $ Spent on BioCloud There is a reason for this. BioCloud was an interesting concept that turned out to be just that.....an interesting concept. It has next to no marketable value. The sooner Ghezzi drops the narrative.....the better. The clowns on CEO believe the lack of BioCloud sales is due to lack of marketing. They are missing the point. Ghezzi is not spending $ on marketing because he knows BioCloud will never turn out to be the device he tricked us all into believing in. It is a dud. He should continue to focus on KNR's core business and the stock price will do well. I see a $3 share price by mid year 2022 and maybe $4 by yearend. I am comfortable with that. I am also comfortable knowing BioCloud has no real intrinsic value to KNR. Drop the BioCloud narrative Ghezzi you can't fool us anymore!